Scientists Found a Protein (‘Mitch’) That May Unlock New Obesity Treatments
Reviewed by the HealthyMag Editorial Team. Last updated: July 2026.
Every so often a piece of lab research escapes the journals and lights up the health headlines. This summer it was a protein with a friendly nickname: “Mitch.” Researchers reported that shutting Mitch down turned ordinary human cells into calorie-hungry fat burners — and stopped new fat cells from forming in the first place. Understandably, the news landed as a possible new obesity treatment, and searches for this fat burning protein spiked overnight.
The science is genuinely interesting. But it is also easy to overstate. Below, we walk through what the researchers actually found, why a drug target is not the same thing as a drug, and — most importantly — what the honest, evidence-based path to fat loss looks like today while this discovery works its way through years of testing.
What scientists actually discovered
The protein at the center of the story is MTCH2 — short for Mitochondrial Carrier Homolog 2, which the researchers affectionately shortened to “Mitch.” The work comes from the lab of Prof. Atan Gross at the Weizmann Institute of Science in Israel, with Dr. Sabita Chourasia as a lead author, and was published in The EMBO Journal.
To understand what Mitch does, it helps to picture the mitochondria — the tiny “power plants” inside your cells that turn food into usable energy. Mitochondria constantly fuse together and split apart, and how they are arranged changes how efficiently a cell produces energy. MTCH2 acts as a kind of switch in that process, promoting mitochondrial fusion and keeping the cell’s energy production tidy and efficient.
Here is the counterintuitive part. When the team deleted Mitch from human cells grown in the lab, the mitochondrial network broke apart into separate units and energy production became less efficient. That left the cells in a state the researchers describe as a constant energy shortage. And a cell that struggles to make energy has to burn more fuel to get by. Monitoring more than 100 metabolic substances every few hours, the team saw a jump in cellular respiration — the cells started consuming more carbohydrates, fats, and even fatty membrane components to keep up. In short, removing the “brake” made the cells burn more.
There was a second effect. When MTCH2 was removed from fat precursor cells — the immature cells that normally mature into fat-storing cells — that maturation stalled. The energy-starved environment simply could not support the transformation, so fewer new fat cells formed.
This human-cell work follows earlier mouse studies (dating back to around 2016) in which suppressing Mitch in muscle tissue left animals resistant to obesity while actually building more muscle fibers and improving endurance. The appeal of a target that burns fat without costing muscle is a big part of why this discovery drew attention.
How it could lead to a new obesity treatment
The key word researchers use is target, not treatment. In drug development, a “target” is a specific molecule in the body that a future medicine might be designed to switch on or off. MTCH2 looks like a promising target because turning it down appears to push cells toward burning fuel rather than storing it — the opposite of what happens in weight gain.
That matters because most of today’s leading obesity medicines work mainly on appetite and food intake. A drug that instead nudges the body’s energy expenditure upward would attack the problem from a different angle. In theory, the two approaches could even be complementary. This is exactly the kind of fresh mechanism that keeps obesity drug research in 2026 moving forward.
But “could be designed” is doing a lot of work in that sentence. Identifying a target is the very first step of a long journey. No one has yet made a safe, selective drug that inhibits MTCH2 in people, and the researchers themselves flag a real concern: forcing cells into a permanent energy-starved, high-stress state could have unwanted consequences. Sorting out whether that stress is a manageable side effect or a dealbreaker is precisely what years of further research are for.
The honest caveat: this is early, preclinical science
It is worth being blunt here, because health headlines rarely are. This research was carried out in laboratory-grown human cells and in mice — not in living humans losing weight. That distinction is everything in metabolism research.
The history of obesity science is littered with molecules that looked spectacular in a dish or in a mouse and then fizzled in people, either because they did not work or because the side effects were unacceptable. The path from “interesting protein” to “approved medicine” typically runs a decade or more and involves animal safety testing, then multiple phases of human trials. Many promising targets never make it at all.
So the accurate framing is this: MTCH2 is an exciting new lead in understanding how the body burns fat, and a plausible future drug target. It is not a pill, not a supplement, and not something that changes what you should do this week, this month, or this year to manage your weight.
The current reality of obesity treatment
While Mitch works its way through the lab, the tools that are actually proven today fall into two well-established buckets: lifestyle change and, for some people, medication.
On the medication side, the biggest shift of the past few years has been the arrival of GLP-1 receptor agonists — the drug class that includes semaglutide and tirzepatide. These work largely by curbing appetite and slowing digestion, and in trials they have produced meaningful weight loss for many patients. Newer entrants aim to make this approach more convenient; we covered one such candidate in our look at the orforglipron weight-loss pill. These medicines are real and effective for eligible patients, but they require a prescription, carry side effects, and are meant to be used under medical supervision — not a shortcut around the basics.
The other bucket is the unglamorous but genuinely proven foundation: how you eat, how you move, and how you sleep. That is where a discovery like Mitch actually connects to something you can act on today, because the science of mitochondria and fat burning is not just a future drug story — it is also a here-and-now lifestyle story.
| Approach | How it works | Evidence status | Available now? |
|---|---|---|---|
| Targeting MTCH2 (“Mitch”) | Removing the protein forces cells to burn more fuel and blocks new fat cells | Preclinical (human cells & mice) | No — a drug target, not a drug |
| GLP-1 medications | Reduce appetite and slow digestion | Proven in large human trials | Yes, by prescription for eligible patients |
| Dietary change (calorie balance) | Creates the energy deficit needed for fat loss | Strong, long-standing evidence | Yes |
| Physical activity & strength training | Raises energy expenditure and helps preserve muscle | Strong, long-standing evidence | Yes |
What actually helps with fat loss now
If the Mitch research inspires anything practical, it is a renewed appreciation for how mitochondria and daily habits shape whether your body leans toward burning or storing. Here is how to burn more fat using tools that already have solid evidence behind them.
Create a sustainable energy deficit. Fat loss ultimately comes down to consistently using more energy than you take in. How you get there is largely a matter of what you can maintain. If you have wondered whether the method matters more than the deficit itself, our comparison of intermittent fasting versus calorie counting digs into what the evidence really shows.
Prioritize protein and strength. Because the appealing part of the Mitch findings was fat loss without muscle loss, it is worth remembering you can protect muscle right now: eat adequate protein and do resistance training. Protein also tends to be more satiating. If you have absorbed the myth that it is fattening, our piece on whether protein makes you fat is worth a read.
Move in ways your mitochondria love. Regular aerobic activity and higher-intensity intervals both improve mitochondrial function and raise energy expenditure — a natural, evidence-backed way to nudge the very machinery MTCH2 sits inside. And you are not too old to start: see our guide to HIIT for older adults for a sensible on-ramp.
Mind sleep and stress. Poor sleep and chronic stress push appetite and metabolism in the wrong direction. They are easy to ignore and genuinely worth protecting.
Frequently Asked Questions
What is the Mitch protein?
“Mitch” is the nickname researchers gave to MTCH2 (Mitochondrial Carrier Homolog 2), a protein that helps control how mitochondria — the cell’s energy plants — fuse together and how efficiently cells produce energy. In lab studies, removing it made human cells burn more fuel and blocked new fat cells from forming.
Is there a new obesity pill based on this?
No. The Mitch findings identify a possible drug target, not a drug. The research was done in human cells and mice, not in people, and no medicine that safely targets MTCH2 exists. Any potential treatment would be years away and is not guaranteed to succeed.
How does the body burn fat?
Your cells break down fats (and carbohydrates) inside mitochondria to release usable energy, a process called cellular respiration. When you consistently use more energy than you consume, your body taps into stored fat to make up the difference. Activity, muscle mass, and healthy mitochondria all influence how much energy you burn.
When will this obesity treatment be available?
There is no timeline, because there is no treatment yet — only a promising research lead. Turning a target into an approved medicine typically takes a decade or more of animal safety work and multiple phases of human trials, and many candidates never make it. It would be misleading to promise a date.
What is the best way to lose fat now?
The evidence-based basics: a sustainable calorie deficit through diet, regular physical activity including strength training to protect muscle, adequate protein, and good sleep. For some people who meet medical criteria, prescription medications like GLP-1 drugs can help — under a doctor’s supervision.
Does this replace GLP-1 drugs?
No. GLP-1 medications are proven and available today; MTCH2 is early-stage research. If anything, a future MTCH2-based drug would work through a different mechanism — boosting energy expenditure rather than curbing appetite — so the two approaches might one day complement each other rather than compete.
Can you boost your metabolism naturally?
You can support it. Building and maintaining muscle through strength training raises the energy your body uses at rest, regular activity increases daily expenditure, and adequate protein has a modestly higher “cost” to digest. There is no magic switch, but these habits meaningfully influence how much fuel you burn — no experimental protein required.
The Bottom Line
The Mitch (MTCH2) discovery is a genuinely intriguing piece of metabolism research: switch off one protein, and human cells shift toward burning fat and away from storing it. It opens a fresh line of inquiry in obesity drug research for 2026 and, in principle, a new class of fat burning treatment that spares muscle. But it is early, preclinical science — cells in a dish and mice, not a pill in a pharmacy. Treat the headlines as exciting news about a possible future, not a change to what works today. The proven path to fat loss remains steady and unglamorous: eat in a sustainable deficit, move regularly, protect your muscle, sleep well, and — if it is medically appropriate for you — talk with a clinician about proven medications. That is not medical advice for your specific situation; it is the honest state of the evidence.
Sources
- ScienceDaily — “Scientists discover a protein switch that burns fat and blocks new fat cells” (Weizmann Institute of Science, MTCH2 / “Mitch”)
- ScienceAlert — “Turning Off One Protein Made Mice Immune to Obesity. Scientists Just Tested It on Human Cells”
- New Atlas — “Scientists discover protein that blocks fat storage and boosts metabolism”
- National Institutes of Health — “Obesity disrupts mitochondria, reduces fat-burning” (background on mitochondria and energy expenditure)
Related
